Middle East News Center: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Center.

Press releases published on September 3, 2026

Sep. 3, 2026

Fortrea adquirirá de Worldwide Clinical Trials las operaciones de la Unidad de Farmacología Clínica y del Laboratorio de Bioanálisis

Indeterminate GlobeNewswire

Sep. 3, 2026

Fortrea acquiert l’unité de pharmacologie clinique et les activités de laboratoire bioanalytique de Worldwide Clinical Trials

Indeterminate GlobeNewswire

Sep. 3, 2026

Fortrea תרכוש את היחידה לפרמקולוגיה קלינית ואת פעילות המעבדה הביו-אנליטית של Worldwide Clinical Trials

Indeterminate GlobeNewswire

Sep. 3, 2026

フォートリア、ワールドワイド・クリニカル・トライアルズから臨床薬理部門およびバイオアナリシスラボ事業を買収

Indeterminate GlobeNewswire

Sep. 3, 2026

Fortrea Akan Mengakuisisi Unit Farmakologi Klinis dan Operasional Laboratorium Bionalitik dari Worldwide Clinical Trials

Indeterminate GlobeNewswire

Sep. 3, 2026

Fortrea, Worldwide Clinical Trials의 임상약리 유닛·생물분석 연구소 사업 인수

Indeterminate GlobeNewswire

Sep. 3, 2026

Fortrea Akan Mengambil Alih Unit Farmakologi Klinikal dan Operasi Makmal Bioanalisis daripada Worldwide Clinical Trials

Indeterminate GlobeNewswire

Sep. 3, 2026

Fortrea Adquire Unidade de Farmacologia Clínica e Operações de Laboratório Bioanalítico da Worldwide Clinical Trials

Indeterminate GlobeNewswire

Sep. 3, 2026

Fortrea 将收购 Worldwide Clinical Trials 的临床药理部门和生物分析实验室业务

Indeterminate GlobeNewswire

Sep. 3, 2026

Fortrea 將收購 Worldwide Clinical Trials 的臨床藥理學部門及生物分析實驗室業務

Indeterminate GlobeNewswire

Sep. 3, 2026

Fortrea เข้าซื้อกิจการหน่วยเภสัชวิทยาคลินิกและการปฏิบัติการห้องปฏิบัติการวิเคราะห์ทางชีวภาพจาก Worldwide Clinical Trial…

Indeterminate GlobeNewswire

Sep. 3, 2026

Nxera Pharma to Receive $8.6 Million Milestone Payment from Centessa Pharmaceuticals Following Late-stage Development Progress

Indeterminate GlobeNewswire

Sep. 3, 2026

Egetis Therapeutics to Participate in Upcoming Investor Conferences in September

Indeterminate GlobeNewswire

Sep. 3, 2026

HUTCHMED Announces Licensing Agreement with GSK for KRAS-EGFR-Antibody Conjugate Cancer Therapy

Indeterminate GlobeNewswire

Sep. 3, 2026

Kensho and Classiq Partner to Expand Access to Quantum Software in Taiwan

Indeterminate GlobeNewswire